(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Trade Finance, Export Lending, Import Credit, Asset Secured
BLX EPS (Earnings per Share)
BLX Revenue
Description: BLX Foreign Trade Bank of Latin
Foreign Trade Bank of Latin America Inc (BLX) is a Panamanian common stock operating in the Specialized Finance sub-industry. The bank provides financial services to Latin American countries, facilitating international trade.
To evaluate BLXs performance, key metrics include Return on Equity (RoE) of 15.63%, indicating the banks ability to generate profits from shareholders equity. The Price-to-Earnings (P/E) ratio of 7.02 suggests that the stock is undervalued relative to its earnings. Market capitalization stands at $1.446 billion, reflecting the companys size and investor confidence.
Economic drivers influencing BLXs performance include Latin Americas trade dynamics, regional economic growth, and the banks ability to navigate complex financial transactions. Key Performance Indicators (KPIs) to monitor include net interest margin, loan growth, and asset quality. The banks exposure to emerging markets and trade finance opportunities positions it for potential growth, driven by increasing demand for financial services in the region.
Investors should consider the banks competitive positioning, risk management practices, and regulatory environment. BLXs beta of 0.84 indicates relatively lower volatility compared to the broader market. The stocks current price is near its 52-week high, suggesting strong recent performance. Average trading volume is around 131,150 shares, indicating moderate liquidity.
BLX Stock Overview
Market Cap in USD | 1,697m |
Sub-Industry | Specialized Finance |
IPO / Inception | 1992-09-24 |
BLX Stock Ratings
Growth Rating | 97.1% |
Fundamental | 55.2% |
Dividend Rating | 85.9% |
Return 12m vs S&P 500 | 34.1% |
Analyst Rating | 4.50 of 5 |
BLX Dividends
Dividend Yield 12m | 5.76% |
Yield on Cost 5y | 26.57% |
Annual Growth 5y | 12.00% |
Payout Consistency | 83.1% |
Payout Ratio | 39.8% |
BLX Growth Ratios
Growth Correlation 3m | 57.6% |
Growth Correlation 12m | 95.3% |
Growth Correlation 5y | 94% |
CAGR 5y | 39.03% |
CAGR/Max DD 5y | 1.26 |
Sharpe Ratio 12m | 1.50 |
Alpha | 43.05 |
Beta | 0.838 |
Volatility | 23.52% |
Current Volume | 64.1k |
Average Volume 20d | 97.3k |
Stop Loss | 44.7 (-3.1%) |
Signal | -0.25 |
Piotroski VR‑10 (Strict, 0-10) 2.0
Net Income (220.4m TTM) > 0 and > 6% of Revenue (6% = 41.5m TTM) |
FCFTA 0.01 (>2.0%) and ΔFCFTA -1.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -754.2% (prev -12.26%; Δ -741.9pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.01 (>3.0%) and CFO 143.3m <= Net Income 220.4m (YES >=105%, WARN >=100%) |
Net Debt (1.81b) to EBITDA (159.1m) ratio: 11.35 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (36.9m) change vs 12m ago 0.45% (target <= -2.0% for YES) |
Gross Margin 42.82% (prev 50.49%; Δ -7.67pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 5.87% (prev 7.43%; Δ -1.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 0.30 (EBITDA TTM 159.1m / Interest Expense TTM 513.4m) >= 6 (WARN >= 3) |
Altman Z'' -2.31
(A) -0.41 = (Total Current Assets 2.19b - Total Current Liabilities 7.40b) / Total Assets 12.67b |
(B) 0.07 = Retained Earnings (Balance) 861.4m / Total Assets 12.67b |
(C) 0.01 = EBIT TTM 156.2m / Avg Total Assets 11.79b |
(D) 0.08 = Book Value of Equity 861.4m / Total Liabilities 11.26b |
Total Rating: -2.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.19
1. Piotroski 2.0pt = -3.0 |
2. FCF Yield 4.00% = 2.00 |
3. FCF Margin 20.26% = 5.06 |
4. Debt/Equity 2.67 = -0.27 |
5. Debt/Ebitda 23.75 = -2.50 |
6. ROIC - WACC -2.31% = -2.89 |
7. RoE 16.23% = 1.35 |
8. Rev. Trend 40.30% = 2.02 |
9. Rev. CAGR -3.42% = -0.57 |
10. EPS Trend 59.48% = 1.49 |
11. EPS CAGR 36.42% = 2.50 |
What is the price of BLX shares?
Over the past week, the price has changed by +0.39%, over one month by +13.88%, over three months by +12.59% and over the past year by +56.85%.
Is Foreign Trade Bank of Latin a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BLX is around 62.51 USD . This means that BLX is currently undervalued and has a potential upside of +35.51% (Margin of Safety).
Is BLX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 47.3 | 2.6% |
Analysts Target Price | 47.3 | 2.6% |
ValueRay Target Price | 67.3 | 45.8% |
Last update: 2025-08-30 04:34
BLX Fundamental Data Overview
CCE Cash And Equivalents = 1.97b USD (Cash only, last quarter)
P/E Trailing = 7.727
P/S = 5.5433
P/B = 1.2168
P/EG = 1.58
Beta = 0.852
Revenue TTM = 691.6m USD
EBIT TTM = 156.2m USD
EBITDA TTM = 159.1m USD
Long Term Debt = 2.54b USD (from longTermDebt, last quarter)
Short Term Debt = 1.24b USD (from shortLongTermDebt, last quarter)
Debt = 3.78b USD (Calculated: Short Term 1.24b + Long Term 2.54b)
Net Debt = 1.81b USD (from netDebt column, last quarter)
Enterprise Value = 3.50b USD (1.70b + Debt 3.78b - CCE 1.97b)
Interest Coverage Ratio = 0.30 (Ebit TTM 156.2m / Interest Expense TTM 513.4m)
FCF Yield = 4.00% (FCF TTM 140.1m / Enterprise Value 3.50b)
FCF Margin = 20.26% (FCF TTM 140.1m / Revenue TTM 691.6m)
Net Margin = 31.87% (Net Income TTM 220.4m / Revenue TTM 691.6m)
Gross Margin = 42.82% ((Revenue TTM 691.6m - Cost of Revenue TTM 395.4m) / Revenue TTM)
Tobins Q-Ratio = 4.07 (Enterprise Value 3.50b / Book Value Of Equity 861.4m)
Interest Expense / Debt = 3.35% (Interest Expense 126.7m / Debt 3.78b)
Taxrate = 21.0% (US default)
NOPAT = 123.4m (EBIT 156.2m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.67 (Debt 3.78b / last Quarter total Stockholder Equity 1.42b)
Debt / EBITDA = 23.75 (Net Debt 1.81b / EBITDA 159.1m)
Debt / FCF = 26.98 (Debt 3.78b / FCF TTM 140.1m)
Total Stockholder Equity = 1.36b (last 4 quarters mean)
RoA = 1.74% (Net Income 220.4m, Total Assets 12.67b )
RoE = 16.23% (Net Income TTM 220.4m / Total Stockholder Equity 1.36b)
RoCE = 4.01% (Ebit 156.2m / (Equity 1.36b + L.T.Debt 2.54b))
RoIC = 2.34% (NOPAT 123.4m / Invested Capital 5.29b)
WACC = 4.65% (E(1.70b)/V(5.48b) * Re(9.10%)) + (D(3.78b)/V(5.48b) * Rd(3.35%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 0.0 | Cagr: -0.09%
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.82% ; FCFE base≈183.5m ; Y1≈120.5m ; Y5≈55.1m
Fair Price DCF = 31.82 (DCF Value 914.4m / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 40.30 | Revenue CAGR: -3.42%
Rev Growth-of-Growth: -82.52
EPS Correlation: 59.48 | EPS CAGR: 36.42%
EPS Growth-of-Growth: -60.59
Additional Sources for BLX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle